Credit: Melanie Gonick, MIT
MIT researchers including Robert Croy (left) and Bogdan Fedeles have discovered that a drug they originally developed as a potential cancer treatment may also hold promise in treating autosomal dominant polycystic kidney disease (ADPKD).